IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.27
-1.25 (-3.97%)
At close: Feb 13, 2026, 4:00 PM EST
30.87
+0.60 (1.98%)
After-hours: Feb 13, 2026, 5:46 PM EST
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.65 billion as of February 13, 2026. Its market cap has increased by 28.57% in one year.
Market Cap
2.65B
Enterprise Value
1.54B
1-Year Change
28.57%
Ranking
Category
Stock Price
$30.27
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.65B, an increase of 1,131.01%. That is a compound annual growth rate of 45.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.65B | -12.44% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 2.99B |
| Denali Therapeutics | 2.93B |
| Spyre Therapeutics | 2.84B |
| Beam Therapeutics | 2.76B |
| Apellis Pharmaceuticals | 2.75B |
| Viridian Therapeutics | 2.66B |
| Tarsus Pharmaceuticals | 2.58B |
| Dyne Therapeutics | 2.56B |